Chiral Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 5.85 Cr
as on 08-07-2024
- Company Age 29 Year, 11 Days
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 43.20 Cr
as on 08-07-2024
- Satisfied Charges ₹ 1.80 Cr
as on 08-07-2024
About Chiral Bio Sciences
The Corporate was formerly known as Chiral Bio Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.85 Cr.
The company currently has active open charges totaling ₹43.20 Cr. The company has closed loans amounting to ₹1.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Avva Prasad, Rameshwar Likki, and Prashanth Gopisetty serve as directors at the Company.
- CIN/LLPIN
U17119TG1995PLC022582
- Company No.
022582
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Dec 1995
- Date of AGM
29 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chiral Bio Sciences Limited offer?
Chiral Bio Sciences Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, API (Active Pharmaceutical Ingredients), Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Diabetes Medicine, Telmisartan Tablets, Blood System and Cardiovascular API.
Who are the key members and board of directors at Chiral Bio Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshwar Likki  | Managing Director | 14-Dec-1995 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avva Prasad | Director | 07-Sep-2006 | Current |
| Prashanth Gopisetty | Director | 01-Apr-2009 | Current |
Financial Performance of Chiral Bio Sciences.
Enhance accessibility to Chiral Bio Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chiral Bio Sciences?
Unlock access to Chiral Bio Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
| Creation Date: 11 Jul 2011 | ₹23.95 Cr | Open |
State Bank Of Hyderabad Creation Date: 13 Jan 2009 | ₹19.25 Cr | Open |
Syndicate Bank Creation Date: 14 Jul 2005 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Chiral Bio Sciences?
Unlock and access historical data on people associated with Chiral Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chiral Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiral Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
